Pharmacokinetic interaction trial between co-artemether and mefloquine
- 20 March 2000
- journal article
- clinical trial
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 10 (2) , 141-151
- https://doi.org/10.1016/s0928-0987(00)00060-9
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Population pharmacokinetics and therapeutic response of CGP 56697 (artemether+benflumetol) in malaria patientsBritish Journal of Clinical Pharmacology, 1998
- Atrial flutter with 1: 1 conduction after administration of the antimalarial drug mefloquineClinical Cardiology, 1996
- Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double‐blind, placebo‐controlled trialBritish Journal of Clinical Pharmacology, 1996
- Mefloquine Effect on Disposition of Halofantrine in the Isolated Perfused Rat LiverJournal of Pharmacy and Pharmacology, 1996
- Clinical Pharmacokinetics of HalofantrineClinical Pharmacokinetics, 1994
- Provocation of ventricular tachycardia by antimalarial drug halofantrine in congenital long QT syndromeClinical Cardiology, 1994
- Cardiac effects of antimalarial treatment with halofantrineThe Lancet, 1993
- MefloquineDrugs, 1993
- Primaquine disposition in the isolated perfused rat liver: Effect of mefloquine induced bile flow reductionBiopharmaceutics & Drug Disposition, 1989
- Inhibition of ethinyloestradiol and tolbutamide metabolism by quinoline derivatives in vitroChemico-Biological Interactions, 1986